<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="css/style.css">
    <title>Derma-Demo</title>
</head>
<body>
    <header>
        <div class="logo-search">
            <div class="logo">
                <img src="images/DermaWorld.png" alt="DermaWorld-Logo">
            </div>
            <div class="search">
                <form action="">
                    <input type="text" placeholder="Search...">
                </form>
            </div>
        </div>
        <nav id="main_nav">
            <a href="#">Bedingungen</a>
            <a href="#">Behandlungen</a>
            <a href="#">Veranstaltungen</a>
            <a href="#">Werkzeuge</a>
            <a href="#">Forschung und Erkenntnisse</a>
        </nav>
        <nav id="secondary_nav" class="hidden"></nav>
        <nav id="third_nav" class="hidden"></nav>
    </header>
    <main>
        <section class="content first-section">
            <div class="overlay"></div>
            <div class="text">
                <img src="images/Adtralzaglobal100820.png" alt="" srcset="">
                <h2>Adtralza® is a new treatment for adult patients with moderate-to-severe atopic dermatitis (eczema) who are candidates for systemic therapy.</h2>
            </div>
            <img src="images/IVA-Cover-ohne-retuschiert.png" alt="the effect">
        </section>
        <section class="content second">
            <div class="image">
                <img src="images/adtralza-packshot-gebaut-01.png" alt="" srcset="">
            </div>
            <div class="text">
                <h2>It is the first and only biologic developed to specifically neutralize IL-13, a key driver of atopic dermatitis signs and symptoms(1,2)</h2>
                <p>Learn more about how Adtralza® works and how to use it in treatment.</p>
            </div>
        </section>
        <section class="content details third">
            <div class="detail">
                <div class="image"><img src="images/Group29612145.svg" alt="" srcset=""></div>
                <div class="text">
                    <h3>Long term sustained improvement</h3>
                    <p>9 out of 10 respondents experienced sustained disease control in clinical trials 10, providing sustained improvements in the burden of disease(1,2, 1, 8*†‡).</p>
                    <a href="#">See efficacy and trial data</a>
                </div>
            </div>
            <div class="detail">
                <div class="image">
                    <img src="images/Group 29612146.svg" alt="" srcset="">
                </div>
                <div class="text">
                    <h3>Improvements in the burden of disease</h3>
                    <p>Patients in clinical trials saw an improvement in Quality of Life with early symptom relief and sustained improvements in burden of disease from week 16 to 32(12,13).</p>
                    <a href="#">Learn more about quality of life improvements</a>
                </div>
            </div>
            <div class="detail">
                <div class="image">
                    <img src="images/Group29612147.svg" alt="" srcset="">
                </div>
                <div class="text">
                    <h3>Good safety profile</h3>
                    <p>The overall frequency and severity of adverse events with Adtralza® were comparable to placebo at 16 weeks* and 52 weeks(19).</p>
                    <a href="#">See safety profile</a>
                </div>
            </div>
        </section>
        <section class="content fourth">
            <div class="text">
                <h2>Adtralza® neutralizes IL-13, a key driver of Atopic Dermatitis signs and symptoms.</h2>
                <p>By specifically targeting the IL-13 cytokine, Adtralza® inhibits the interaction with type II receptors and prevents IL-13-induced inflammatory responses in the skin(1,2).

                    Adtralza® selectively modulates the dysregulated immune system by(1): 
                    
                    — Reducing markers of skin inflammation 
                    — Improving markers of skin barrier integrity 
                    — Reducing epidermal thickness</p>
                <a href="#">Watch the video</a>
                <sub>Duration: 2:43</sub>
            </div>
            <div class="image">
                <img src="images/image11.jpg" alt="" srcset="">
            </div>
        </section>
        <section class="content fifth">
            <h2>Clinical tools - at a glance</h2>
            <div class="articles">
            <div class="article">
                <img src="images/GettyImages-1139665867.png" alt="" srcset="">
                <div class="text">
                    <h2>Dosing guide</h2>
                    <p>Adtralza® has a straightforward dosing regimen, with 150 mg prefilled syringes(1). </p>
                    <a href="#">Learn more about application and dosing</a>
                </div>
            </div>
            <div class="article">
                <img src="images/Screenshot.png" alt="" srcset="">
                <div class="text">
                <h2>Patient injection made simple</h2>
                <p>This step by step video guide shows the patient how to self inject using the two syringes that come in the Adtralza® carton.</p>
                <a href="#">Watch the video</a>
            </div>
            </div>
            </div>
        </section>
        <section class="content sixth">
            <div class="video_container">
                <div class="image">
                    <iframe width="250" height="150" src="https://www.youtube.com/embed/ceu-pA5JNQg" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>
                </div>
                <div class="text">Short description of the contents or subject of the video.  You can upload a screen from the video as thumbnail image</div>
            </div>
            <div class="video_container">
                <div class="image">
                    <iframe width="250" height="150" src="https://www.youtube.com/embed/ceu-pA5JNQg" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>
                </div>
                <div class="text">Short description of the contents or subject of the video.  You can upload a screen from the video as thumbnail image</div>
            </div>
            <div class="video_container">
                <div class="image">
                    <iframe width="250" height="150" src="https://www.youtube.com/embed/ceu-pA5JNQg" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>
                </div>
                <div class="text">Short description of the contents or subject of the video.  You can upload a screen from the video as thumbnail image</div>
            </div>
            <div class="video_container">
                <div class="image">
                    <iframe width="250" height="150" src="https://www.youtube.com/embed/ceu-pA5JNQg" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>
                </div>
                <div class="text">Short description of the contents or subject of the video.  You can upload a screen from the video as thumbnail image</div>
            </div>
        </section>
    </main>
    <footer>

    </footer>
</body>
</html>